Regardless of currently being manufactured for less than $five a month, copyright carries a retail value which is difficult to justify. The numerous hole involving creation prices and pricing raises important questions about the pharmaceutical market's pricing tactics.California biotech behemoth Amgen ditched strategies for an experimental weight l